● Recruiting

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Condition: Hepatocellular Carcinoma · Sponsor: Sun Yat-sen University

PhasePhase 3

Planned participants230

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

To compare the impact on survival of neo-adjuvant TAI for patients with HCC and PVTT who underwent hepatectomy.

This description comes directly from the study's public registry record.

Talk to the study team

Shaohua Li, MD · +8615088064187 · lishaoh@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Cancer Center of Sun Yat-Sen University

Guangzhou, Guangdong, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03368651